NISA INVESTMENT ADVISORS, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,053
-58.6%
1,440
-7.0%
0.00%
Q2 2023$7,373
+23683.9%
1,549
-71.9%
0.00%
Q1 2023$31
+933.3%
5,505
+1735.0%
0.00%
Q4 2022$3
-100.0%
300
-87.8%
0.00%
Q3 2022$51,000
-1.9%
2,462
+17.2%
0.00%
Q2 2022$52,000
-42.9%
2,100
-11.0%
0.00%
-100.0%
Q1 2022$91,000
-13.3%
2,360
-7.1%
0.00%0.0%
Q4 2021$105,000
-39.0%
2,540
-12.4%
0.00%0.0%
Q3 2021$172,000
-36.1%
2,900
-6.5%
0.00%
-50.0%
Q2 2021$269,000
-7.6%
3,100
-12.2%
0.00%0.0%
Q1 2021$291,000
-18.5%
3,530
-10.2%
0.00%0.0%
Q4 2020$357,000
+264.3%
3,930
+60.1%
0.00%
+100.0%
Q3 2020$98,000
+415.8%
2,455
+342.3%
0.00%
Q2 2020$19,000
+58.3%
555
+5.7%
0.00%
Q1 2020$12,0000.0%525
-12.5%
0.00%
Q4 2019$12,000
+33.3%
6000.0%0.00%
Q3 2019$9,0000.0%600
+39.5%
0.00%
Q2 2019$9,000
+12.5%
4300.0%0.00%
Q1 2019$8,000
+33.3%
4300.0%0.00%
Q4 2018$6,000
-14.3%
4300.0%0.00%
Q3 2018$7,0004300.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders